当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:578.14亿  总市值:729.01亿
流通股本:21.18亿   总股本:26.71亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润25.19亿元,每股收益0.75元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益5919460.42万元,未分配利润2582790.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产11526476.18万元,负债5607015.76万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入30,911,889,002.920,462,812,731.1510,157,255,262.441,399,539,588.42
营业总成本29,362,812,762.8519,408,879,676.269,522,433,489.9141,284,076,914.38
营业利润3,107,588,817.821,929,286,791.651,021,364,060.983,307,507,905.12
利润总额3,071,565,885.41,931,200,793.341,018,423,857.093,264,567,878.74
净利润2,518,517,637.461,549,731,977.11786,221,155.862,895,063,426.58
其他综合收益-213,927,299.31112,419,919.1891,154,209.9731,857,159.28
综合收益总额2,304,590,338.151,662,151,896.29877,375,365.832,926,920,585.86
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计34,527,299,352.0534,797,913,650.7533,839,364,765.2233,792,568,948.62
非流动资产合计80,737,462,405.0980,739,900,515.1479,906,424,660.3979,677,035,864.83
资产总计115,264,761,757.14115,537,814,165.89113,745,789,425.61113,469,604,813.45
流动负债合计37,517,582,094.3737,401,861,771.4433,602,092,132.7433,757,583,537.82
非流动负债合计18,552,575,493.1419,274,010,769.3922,608,023,220.3923,095,760,839.35
负债合计56,070,157,587.5156,675,872,540.8356,210,115,353.1356,853,344,377.17
归属于母公司股东权益合计47,301,473,095.2446,967,200,004.1446,345,852,168.6245,684,761,548.05
股东权益合计59,194,604,169.6358,861,941,625.0657,535,674,072.4856,616,260,436.28
负债和股东权益合计115,264,761,757.14115,537,814,165.89113,745,789,425.61113,469,604,813.45
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计31,551,927,328.3920,745,072,818.2210,300,650,067.6844,365,904,091.82
经营活动现金流出小计28,565,289,973.2218,838,068,920.229,383,337,962.6540,951,687,028.23
经营活动产生的现金流量净额2,986,637,355.171,907,003,898917,312,105.033,414,217,063.59
投资活动现金流入小计1,823,762,368.12516,001,223.51376,935,106.133,753,440,599.98
投资活动现金流出小计4,263,474,836.993,165,950,137.691,568,066,271.677,572,730,972.4
投资活动产生的现金流量净额-2,439,712,468.87-2,649,948,914.18-1,191,131,165.54-3,819,290,372.42
筹资活动现金流入小计23,965,139,058.3117,913,255,802.798,178,024,612.0923,590,297,864.13
筹资活动现金流出小计24,467,428,47116,822,691,626.938,079,386,988.4924,926,547,662.99
筹资活动产生的现金流量净额-502,289,412.691,090,564,175.8698,637,623.6-1,336,249,798.86
汇率变动对现金及现金等价物的影响-69,635,970.1417,131,450.2123,437,769.8973,645,025.18
现金及现金等价物净增加额-25,000,496.53364,750,609.89-151,743,667.02-1,667,678,082.51
期末现金及现金等价物余额9,477,388,409.519,867,139,515.939,350,645,239.029,502,388,906.04
最新报告期:2024-09-10
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信证券陈竹1.191.521.872024-09-10
国联证券夏禹,郑薇1.401.701.902024-08-28
TOP↑